(Q36526860)

14 August 2017

1 reference

title

The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites (English)

1 reference

14 August 2017

0 references

1 reference

Guadalupe Garcia-Tsao

series ordinal

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

Nature Reviews Gastroenterology & Hepatology

14 August 2017

published in

1 reference

14 August 2017

volume

3

1 reference

14 August 2017

issue

7

1 reference

14 August 2017

page(s)

380-389

1 reference

Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

Histologic spectrum of alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

Compensated cirrhosis: Natural history and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Survival and prognostic indicators in compensated and decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Portal hypertension: a permissive factor only in the development of ascites and variceal bleeding

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Portasystemic shunting procedures for portal hypertension. Twenty-six year experience in adults with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Signed consent for publication

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Transjugular intrahepatic portosystemic shunt in the management of refractory ascites

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Clinical, laboratory, psychometric, and electroencephalographic investigations

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics in cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

The North American Study for the Treatment of Refractory Ascites

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

TIPS for management of refractory ascites: response and survival are both unpredictable

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results in a patient cohort observed for 3-9 years

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Benefit of TIPS for patients with refractory or recidivant ascites: serum bilirubin may make the difference

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0523

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP0523

1 reference

Dimensions Publication ID

14 August 2017

1014855438

0 references

1 reference